Clonazepam/haloperidol combination therapy in schizophrenia: A double blind study

A. C. Altamura, M. C. Mauri, M. Mantero, M. Brunetti

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Clonazepam (CLN), a benzodiazepine originally used as an anti-epileptic, was tested in schizophrenia in a double blind comparison in combination with haloperidol (HL). Twenty-four schizophrenic inpatients, diagnosed according to DSM III were treated with HL and CLN (Group I) or HL and placebo (Group 2) for 4 weeks. The Brief Psychiatric Rating Scale (BPRS) and the Extrapyrimidal Side Effect Scale (EPSE) were used for assessing psychopathological features and extra-pyramidal side-effects before treatment and then weekly. No differences in specific schizophrenic symptoms were detected between the two groups, but in Group 1 an early significant BPRS amelioration was noticed compared in Group 2. Moreover, the excitement item improved singificantly in Group 1 only, from the second week. Less severe EPSE scores were observed in Group 1 in comparison to Group 2. In conclusion the combination of CLN and HL seems to be preferred to HL alone in cases of psychotic excitement and in order to reduce the severity of extrapyramidal side-effects.

Original languageEnglish
Pages (from-to)702-706
Number of pages5
JournalActa Psychiatrica Scandinavica
Volume76
Issue number6
Publication statusPublished - 1987

Fingerprint

Clonazepam
Haloperidol
Double-Blind Method
Schizophrenia
Brief Psychiatric Rating Scale
Therapeutics
Benzodiazepines
Diagnostic and Statistical Manual of Mental Disorders
Inpatients
Placebos

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Clonazepam/haloperidol combination therapy in schizophrenia : A double blind study. / Altamura, A. C.; Mauri, M. C.; Mantero, M.; Brunetti, M.

In: Acta Psychiatrica Scandinavica, Vol. 76, No. 6, 1987, p. 702-706.

Research output: Contribution to journalArticle

@article{c9e99056f4f4421b85677710b02495e0,
title = "Clonazepam/haloperidol combination therapy in schizophrenia: A double blind study",
abstract = "Clonazepam (CLN), a benzodiazepine originally used as an anti-epileptic, was tested in schizophrenia in a double blind comparison in combination with haloperidol (HL). Twenty-four schizophrenic inpatients, diagnosed according to DSM III were treated with HL and CLN (Group I) or HL and placebo (Group 2) for 4 weeks. The Brief Psychiatric Rating Scale (BPRS) and the Extrapyrimidal Side Effect Scale (EPSE) were used for assessing psychopathological features and extra-pyramidal side-effects before treatment and then weekly. No differences in specific schizophrenic symptoms were detected between the two groups, but in Group 1 an early significant BPRS amelioration was noticed compared in Group 2. Moreover, the excitement item improved singificantly in Group 1 only, from the second week. Less severe EPSE scores were observed in Group 1 in comparison to Group 2. In conclusion the combination of CLN and HL seems to be preferred to HL alone in cases of psychotic excitement and in order to reduce the severity of extrapyramidal side-effects.",
author = "Altamura, {A. C.} and Mauri, {M. C.} and M. Mantero and M. Brunetti",
year = "1987",
language = "English",
volume = "76",
pages = "702--706",
journal = "Acta Psychiatrica Scandinavica",
issn = "0001-690X",
publisher = "wiley",
number = "6",

}

TY - JOUR

T1 - Clonazepam/haloperidol combination therapy in schizophrenia

T2 - A double blind study

AU - Altamura, A. C.

AU - Mauri, M. C.

AU - Mantero, M.

AU - Brunetti, M.

PY - 1987

Y1 - 1987

N2 - Clonazepam (CLN), a benzodiazepine originally used as an anti-epileptic, was tested in schizophrenia in a double blind comparison in combination with haloperidol (HL). Twenty-four schizophrenic inpatients, diagnosed according to DSM III were treated with HL and CLN (Group I) or HL and placebo (Group 2) for 4 weeks. The Brief Psychiatric Rating Scale (BPRS) and the Extrapyrimidal Side Effect Scale (EPSE) were used for assessing psychopathological features and extra-pyramidal side-effects before treatment and then weekly. No differences in specific schizophrenic symptoms were detected between the two groups, but in Group 1 an early significant BPRS amelioration was noticed compared in Group 2. Moreover, the excitement item improved singificantly in Group 1 only, from the second week. Less severe EPSE scores were observed in Group 1 in comparison to Group 2. In conclusion the combination of CLN and HL seems to be preferred to HL alone in cases of psychotic excitement and in order to reduce the severity of extrapyramidal side-effects.

AB - Clonazepam (CLN), a benzodiazepine originally used as an anti-epileptic, was tested in schizophrenia in a double blind comparison in combination with haloperidol (HL). Twenty-four schizophrenic inpatients, diagnosed according to DSM III were treated with HL and CLN (Group I) or HL and placebo (Group 2) for 4 weeks. The Brief Psychiatric Rating Scale (BPRS) and the Extrapyrimidal Side Effect Scale (EPSE) were used for assessing psychopathological features and extra-pyramidal side-effects before treatment and then weekly. No differences in specific schizophrenic symptoms were detected between the two groups, but in Group 1 an early significant BPRS amelioration was noticed compared in Group 2. Moreover, the excitement item improved singificantly in Group 1 only, from the second week. Less severe EPSE scores were observed in Group 1 in comparison to Group 2. In conclusion the combination of CLN and HL seems to be preferred to HL alone in cases of psychotic excitement and in order to reduce the severity of extrapyramidal side-effects.

UR - http://www.scopus.com/inward/record.url?scp=0023621979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023621979&partnerID=8YFLogxK

M3 - Article

C2 - 3327370

AN - SCOPUS:0023621979

VL - 76

SP - 702

EP - 706

JO - Acta Psychiatrica Scandinavica

JF - Acta Psychiatrica Scandinavica

SN - 0001-690X

IS - 6

ER -